B io te c h T h e ra p e u t ic F in a n c in g R o u n d ... · Silverback Therapeutics Inc. Biotechnology - Therapeutics and Diagnostics 78.50 Series B / 2. Round Equity (private)

Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20

Financing Value EU 67 265 542 234 72 529 129 60 130 161 88 216

Financing Value US 1008 560 581 707 393 364 1085 451 658 491 333 1473

Number of Rounds EU 6 13 10 11 4 17 10 6 8 9 6 6

Number of Rounds US 24 14 16 13 11 10 23 12 15 11 8 22

0

5

10

15

20

25

30

0

200

400

600

800

1000

1200

1400

1600

1800

Nu

mb

er o

f R

ou

nd

s

Tota

l Val

ue

in M

illio

n U

SD

Biotech Therapeutic Financing Rounds Private Equity

20%15% 12%

8%

4% 11%11%

9%

34%38%

39%

30%

26%

25%24%

31%

10%

6%9% 18%

4% 2% 4% 3%

0%

25%

50%

75%

100%

Q2 2019 Q3 2019 Q4 2019 Q1 2020

% o

f To

tal D

eal

s

Quarter & Year

Series Rounds as % of Total Biotech Therapeutics and Diagnostics

Series D / 4. Round

Series C / 3. Round

Series B / 2. Round

Series A / 1. Round

Seed Round

Other or n/a

18%13% 15% 14%

26% 36%26%

18%

18%15%

18%

18%

38% 36% 42%49%

0%

25%

50%

75%

100%

Q2 2019 Q3 2019 Q4 2019 Q1 2020

% o

f To

tal D

eal

s

Quarter & Year

Investment Size as % of Total Biotech Therapeutics and Diagnostics

30m+

15m-30m

5m-15m

<5m

Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar

2019 2019 2019 2019 2019 2019 2019 2019 2019 2020 2020 2020

Total value 1'351 823 2'210 605 428 1'360 1'095 1'100 243 512 2'914 364

Number 8 10 10 5 4 6 10 7 2 6 7 2

0

2

4

6

8

10

12

0

500

1000

1500

2000

2500

3000

3500

Nu

mb

er o

f IP

Os

Tota

l Val

ue

in M

illio

n U

SD

Life Science Company IPOs Worldwide

Company Name Sector Amount (in Million

USD)

Type of Round

Financing Stage

Ownership Country Date

InnoCare Pharma

Biotechnology - Therapeutics

and Diagnostics

289.00 NA IPO Publicly listed on stock exchange

China (Mainland)

17-Mar-20

Zogenix Inc. Biotechnology - Therapeutics

and Diagnostics

230.30 NA Post-IPO Publicly listed on stock exchange

USA 06-Mar-20

Karyopharm Therapeutics Inc.


and Diagnostics


USA 06-Mar-20

Immunocore Limited


and Diagnostics

130.00 Series B / 2. Round

Equity (private)

Private / independent

United Kingdom

02-Mar-20

Nurix Inc. Biotechnology - Therapeutics

and Diagnostics

120.00 Other Equity (private)


USA 12-Mar-20

Kallyope Inc. Biotechnology - Therapeutics

and Diagnostics

112.00 Series C / 3. Round

Equity (private)


USA 25-Mar-20

SutroVax Inc. Biotechnology - Therapeutics

and Diagnostics

110.00 Series D / 4. Round

Equity (private)


USA 26-Mar-20

Akouos Inc. Biotechnology - Therapeutics

and Diagnostics


Equity (private)


USA 03-Mar-20

Kymera Therapeutics LLC


and Diagnostics


Equity (private)


USA 12-Mar-20

Xilio Therapeutics


and Diagnostics


Equity (private)


USA 02-Mar-20

AVROBIO Inc. Biotechnology - Therapeutics

and Diagnostics


USA 18-Mar-20

Tempus Labs Inc.

Biotechnology - R&D Services

100.00 Series G / 7.

Round

Equity (private)


USA 13-Mar-20

Pliant Therapeutics Inc.


and Diagnostics


Equity (private)


USA 03-Mar-20

Sigilon Therapeutics Inc.


and Diagnostics


Equity (private)


USA 17-Mar-20

ReCode Therapeutics


and Diagnostics

80.00 Series A / 1. Round

Equity (private)


USA 26-Mar-20

http://www.biotechgate.com/?utm_source=deal%20report

Silverback Therapeutics Inc.


and Diagnostics


Equity (private)


USA 11-Mar-20

Castle Creek Biosciences Inc.


and Diagnostics

75.00 NA Debt financing


USA 25-Mar-20

Compugen Ltd. Biotechnology - Therapeutics

and Diagnostics


Israel 16-Mar-20

Imara Inc. Biotechnology - Therapeutics

and Diagnostics

75.00 NA IPO Publicly listed on stock exchange

USA 12-Mar-20

Harbour BioMed


and Diagnostics


Equity (private)


USA 12-Mar-20

Amunix Operating Inc.


and Diagnostics


Equity (private)


USA 04-Mar-20

Abbisko Therapeutics Co. Ltd.


and Diagnostics


Equity (private)


China (Mainland)

25-Mar-20

Apexigen Inc Biotechnology - Therapeutics

and Diagnostics


Equity (private)


USA 24-Mar-20

DermTech Biotechnology - R&D Services


Publicly listed on stock exchange

USA 02-Mar-20

Affinia Therapeutics


and Diagnostics


Equity (private)


USA 31-Mar-20

Nanjing IASO Biotherapeutics (IASO BIO) Co. Ltd.


and Diagnostics


Equity (private)


China (Mainland)

23-Mar-20

Sientra Inc. Medical Technology

60.00 NA Convertible loan


USA 11-Mar-20

Keros Therapeutics


and Diagnostics


Equity (private)


USA 04-Mar-20

Verrica Pharmaceuticals Inc.


and Diagnostics

55.00 NA Debt financing


USA 11-Mar-20

Shanghai ZhenGe Biotechnology Co.Ltd.



Equity (private)


China (Mainland)

30-Mar-20

AM-Pharma B.V.


and Diagnostics



Netherlands 31-Mar-20

Design Therapeutics


and Diagnostics


Equity (private)


USA 20-Mar-20

Circle Pharma Biotechnology - Therapeutics

and Diagnostics


Equity (private)


USA 17-Mar-20

Eureka Therapeutics Inc.


and Diagnostics

45.00 Series E / 5. Round

Equity (private)


USA 17-Mar-20

Regenacy Pharmaceuticals LLC


and Diagnostics


Equity (private)


USA 25-Mar-20

Sight Sciences Inc.

Medical Technology

30.00 Series E / 5. Round

Equity (private)


USA 18-Mar-20

Evonetix Ltd Biotechnology - R&D Services


Equity (private)


United Kingdom

02-Mar-20

Numab Therapeutics AG


and Diagnostics


Equity (private)


Switzerland 09-Mar-20

Zucara Therapeutics Inc.


and Diagnostics


Equity (private)


Canada 31-Mar-20

EXUMA Biotech Inc.


and Diagnostics


Equity (private)


USA 12-Mar-20

BioSight Ltd. Biotechnology - Therapeutics

and Diagnostics


Equity (private)


Israel 11-Mar-20

Pristine Surgical LLC

Medical Technology


Equity (private)


USA 17-Mar-20

Synairgen plc Biotechnology - Therapeutics

and Diagnostics


United Kingdom

26-Mar-20

Tonix Pharmaceuticals Holding Corp.


and Diagnostics


USA 03-Mar-20

Redpin Therapeutics Inc.


and Diagnostics


Equity (private)


USA 25-Mar-20

CytoDyn Inc. Biotechnology - Therapeutics

and Diagnostics

15.00 NA Convertible loan


USA 31-Mar-20

BillionToOne Inc.



Equity (private)


USA 10-Mar-20

Guangzhou Targene Biotech Co.Ltd.


and Diagnostics


Equity (private)


China (Mainland)

31-Mar-20

Asieris Pharmaceuticals


and Diagnostics


Equity (private)


China (Mainland)

24-Mar-20

OncoOne Research & Development GmbH


and Diagnostics


Equity (private)


Austria 19-Mar-20

Zosano Pharma Inc.


and Diagnostics


USA 06-Mar-20

Biotalys NV Biotechnology - other


Equity (private)


Belgium 05-Mar-20

Tiziana Life Sciences plc


and Diagnostics


United Kingdom

16-Mar-20

Centerline Biomedical Inc

Medical Technology



USA 10-Mar-20

BrainStorm Cell Therapeutics Inc.


and Diagnostics


USA 06-Mar-20

Akari Therapeutics Plc


and Diagnostics


United Kingdom

04-Mar-20

CN Bio Innovations Limited




United Kingdom

02-Mar-20

Zeto Inc Medical Technology


Equity (private)


USA 10-Mar-20

InVivo Therapeutics Corporation

Medical Technology


USA 11-Mar-20

Primmune Therapeutics Inc.


and Diagnostics

7.00 Seed Round

Equity (private)


USA 02-Mar-20

Cocrystal Pharma Inc.


and Diagnostics


USA 11-Mar-20

MedinCell S.A. Biotechnology - Therapeutics

and Diagnostics

6.40 NA Grants / gov.

subvention


France 25-Mar-20

Kitov Pharmaceuticals


and Diagnostics


Israel 17-Mar-20

Kinnos Inc. Biotechnology - other

6.00 Seed Round

Equity (private)


USA 05-Mar-20

Eyenovia Inc. Biotechnology - Therapeutics

and Diagnostics


USA 24-Mar-20

Titan Pharmaceuticals Inc.

Medical Technology


USA 05-Mar-20

AIkido Pharma Inc.


and Diagnostics


USA 10-Mar-20

Armata Pharmaceuticals Inc.


and Diagnostics


subvention


USA 18-Mar-20

Inovio Pharmaceuticals Inc.


and Diagnostics


subvention


USA 12-Mar-20

CellFE Inc. Biotechnology - Therapeutics

and Diagnostics

4.80 Seed Round

Equity (private)


USA 31-Mar-20

Cobra Biologics Biotechnology - R&D Services


subvention


United Kingdom

30-Mar-20

ShiraTronics Inc. Medical Technology


Equity (private)


USA 26-Mar-20

AdaptVac Biotechnology - Therapeutics

and Diagnostics


subvention


Denmark 09-Mar-20

ExpreS2ion Biotechnologies



subvention

Subsidiary Denmark 06-Mar-20

Concure Oncology

Medical Technology



USA 19-Mar-20

TISSIUM Medical Technology


subvention


France 03-Mar-20

ZBiotics Company

Biotechnology - other

2.30 Seed Round

Equity (private)


USA 12-Mar-20

Toxys B.V. Biotechnology - R&D Services



Netherlands 12-Mar-20

Syndivia SAS Biotechnology - Therapeutics

and Diagnostics



France 10-Mar-20

E25Bio Inc. Biotechnology - R&D Services



USA 18-Mar-20

EnduRx Pharmaceuticals Inc.


and Diagnostics


subvention


USA 01-Mar-20

Titan Medical Inc.

Medical Technology


Canada 25-Mar-20

PolyProx Therapeutics Ltd


and Diagnostics

1.00 Seed Round

Equity (private)


United Kingdom

02-Mar-20

Genmark Diagnostics Inc



subvention


USA 23-Mar-20

Diasorin Molecular LLC



subvention

Subsidiary USA 13-Mar-20

54gene Biotechnology - R&D Services



Nigeria 26-Mar-20

Karyopharm Therapeutics Inc.


and Diagnostics


subvention


USA 31-Mar-20

54gene Biotechnology - R&D Services


subvention


Nigeria 26-Mar-20

http://www.biotechgate.com/financing?utm_source=deal%20report

http://www.biotechgate.com/?utm_source=deal%20report

https://www.biotechgate.com/gate/v3/companies.php?utm_source=deal%20report

http://www.venturevaluation.com/?utm_source=deal%20report

Documents

B io te c h T h e ra p e u t ic F in a n c in g R o u n d ... · Silverback Therapeutics Inc. Biotechnology - Therapeutics and Diagnostics 78.50 Series B / 2. Round Equity (private)